Abbi R Saniabadi 1, Tomotaka Tanaka 2, Takayuki Yamamoto 3, Wolfgang Kruis 4, Rodolfo Sacco 5 , J Clin Apher 2019 Feb;34(1):51-60.
Scientific corner
Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes.
Accordingly, for responder patients, GMA fulfills a desire to be treated without drugs.
Contact UsFor more information
Contact Us